The investment round was led by Northstar Ventures with participation from Creative UK and angel investors.
"We are very pleased to complete our investment in Moralbox, which is the third investment from our Venture Sunderland Fund. The Fund supports innovative and scalable businesses with ambitious teams in Sunderland at all stages of their development. Moralbox is developing impressive AI powered training management software and is already working with well-established customers in key industries. We look forward to working with Gordon, John, Steve and the entire Moralbox team to accelerate the company’s growth."
The funding round was led by DSW Ventures with participation from XTX Ventures, Cambridge Technology Capital, angel investors, and Innovate UK.
"Our machine could pick up cancer, HIV or sepsis earlier – any disease with a nucleic acid trace. We’re made of DNA – that’s the source code. If you can pick up traces of faults and errors in that code, you can detect problems across the board before symptoms appear. We’ve built the ultimate needle-in-a-haystack detector – a tool that we can put in the hands of scientists to enable the discoveries of tomorrow."
The seed round was led by Headline to support team expansion and international growth.
"Most procurement tools on the market ask enterprises to completely overhaul existing systems and start fresh. We took the opposite approach. Our platform sits on top of fragmented data landscapes and makes them intelligible – enriching what’s there rather than replacing it. That’s why we can deliver ROI in months, not years, and why our clients see us as a true partner rather than another vendor,"
SFC Capital led the round with backing from the University of Strathclyde and Scottish Enterprise.
"The wellbeing of those who serve on the front lines is paramount. Sentinel exists to ensure that the people who protect and care for others receive the same care in return. This investment allows us to expand our impact and further develop our evidence-based tools for trauma prevention, management and recovery."
The financing round was led by Lunar Ventures to support product commercialisation and clinical development.
"Menstruation is known as the fifth vital sign, but has historically been overlooked by the wearable sector, leaving millions without the data they need to understand and advocate for their own bodies. We envision a future where menstrual health is measured and understood as comprehensively as cardiovascular or metabolic health, giving people access to objective, actionable insights to better manage their health and wellbeing."
.png)
